mMRC Dyspnea Scale
Modified Medical Research Council scale for grading breathlessness severity
Calculator
Why use it
Simple patient-reported outcome measure. Key component of GOLD COPD classification. Guides treatment escalation in COPD. Correlates with quality of life and exercise capacity.
About
The modified Medical Research Council (mMRC) Dyspnea Scale grades the severity of breathlessness during daily activities on a 0-4 scale. It is a key component of the GOLD COPD assessment framework (combined with FEV1 and exacerbation history) to guide COPD treatment decisions.
When to use
- COPD assessment and GOLD classification
- Baseline dyspnea evaluation in chronic respiratory disease
- Monitoring symptom progression over time
- Pulmonary rehabilitation assessment
Formula
Pearls & pitfalls
- mMRC ≥ 2 defines "more symptoms" in the GOLD ABCD/ABE assessment tool.
- mMRC correlates with 6-minute walk distance and quality of life measures.
- It is a SELF-REPORTED scale — ask the patient to choose the statement that best describes their limitation.
- Does not capture all dyspnea dimensions — CAT score provides more comprehensive assessment.
- mMRC is static (daily activities) vs. Borg scale which is dynamic (during exercise).
Next steps
mMRC 0-1: Less symptomatic (GOLD Group A or B). mMRC ≥ 2: More symptomatic (GOLD Group E if ≥ 2 exacerbations). Combine with CAT score, spirometry, and exacerbation history for complete GOLD assessment.
Evidence
Original MRC breathlessness scale (1959). Modified version validated by Bestall et al. (Thorax, 1999). Adopted by GOLD as a key symptom measure for COPD classification since 2011.
References
- Bestall JC et al. Usefulness of the Medical Research Council (MRC) dyspnoea scale. Thorax. 1999;54(7):581-586. — link